An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver
disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis …

The pathophysiology of NAFL and NASH is complex and numerous intermediaries are
involved. Each year brings new and exciting developments as pieces of the …

Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic pathology in
industrialized countries, affecting about 25% of the general population. NAFLD is a benign …

Background Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease worldwide. The increasing prevalence of NAFLD mirrors that of obesity and type 2 …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of abnormal liver tests
in industrial countries. It encompasses the spectrum of liver damage from simple steatosis to …

A need exists to noninvasively assess renal interstitial fibrosis, a common process to all
kidney diseases and predictive of renal prognosis. In this translational study, Magnetic …

Tissues including liver stiffen and acquire more extracellular matrix with fibrosis. The
relationship between matrix content and stiffness, however, is non-linear, and stiffness is …

Aim Diagnosis of nonalcoholic steatohepatitis (NASH) relies on liver biopsy. Noninvasive
tools would be useful to target patients to refer for a biopsy. We aimed to determine the …

Obesity is associated with significant comorbidities, including non-alcoholic fatty liver
disease (NAFLD). Given its potential to progress to advanced liver disease, monitoring the …

Nonalcoholic fatty liver disease (NAFLD) has rapidly become the most common form of
chronic liver disease in the United States affecting approximately 80–100 million Americans …